Tyler E. Jacks's most recent trade in AMGEN Inc. was a trade of 809 Common Stock done . Disclosure was reported to the exchange on May 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Amgen | Tyler E. Jacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 809 | 17,193 (0%) | 0% | 0 | Common Stock | |
Thermo Fisher | Tyler E. Jacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 565 | 8,963 (0%) | 0% | 0 | Common Stock | |
Amgen | Tyler E. Jacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 719 | 16,005 (0%) | 0% | 0 | Common Stock | |
Thermo Fisher | Tyler E. Jacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 339 | 8,398 (0%) | 0% | 0 | Common Stock |